echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Jiangsu open a batch of large infusion hanging net price, cheaper than mineral water!

    Jiangsu open a batch of large infusion hanging net price, cheaper than mineral water!

    • Last Update: 2020-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [
    dynamic pharmaceutical industry network Recently, Jiangsu Provincial Public Resource Exchange Center issued "on the basis of publicity infusion finalists provincial hanging price of notice." According to the notification, Jiangsu Province price adjustment has been shortlisted on the basis of the infusion, the municipalities and districts in the price of the product as a low-cost provincial hanging hanging net price, time for the announcement in 2020 to 5 May 13 May 19, 17:00It is understood that the infusion means and capacity is greater than or equal 50ml intravenously directly enter the sterile liquid formulation in vivo, their clinical use, the infusion can be divided into five categories: balancing fluid infusion, nutrition infusion, blood volume expansion infusion, infusion of therapeutic drugs and dialysis contrast classesSince clinical applications, the infusion product packaging containers through three generations change, packaging materials currently on the market presence of our major infusion glass bottles, plastic bottle, non-PVC soft bag and stand-up pouches four formsinfusion preparation is one of the five categories of the important pharmaceutical industryKey benefits include: supplement the body of water and electrolytes, maintaining acid-base balance of the body; as a carrier for intravenous administration, suitable for intravenous administration of various drugs by infusion delivery mode; when various rescue shock patients, can play administration and rapid volume expansion of the role; critically ill patients for long-term oral administration can not eat, can be supplemented by nutritional infusion of energy and so onIt is reported that 98% of all hospitalized patients using an infusion product as a basic treatmentAlthoughhuge user base, but its price has been fallingI query data found that as early as 2004, the price of a bottle of 500ml glucose and sodium chloride injection to only about 1.3 to 1.5 yuanWhen we encounter a major infusion companies price war, the price is as low as 0.85 yuan, the wholesale price of a bottle of mineral water is almost the sameThis time, according to the notification issued by Jiangsu, 500ml glucose and sodium chloride injection products a total of 37, with prices ranging from 1.11 to 7.5 yuan toAmong them, the price of 22 products or 1 yuan to 2 yuanLower prices only, small business Nanjing Pharmaceutical 0.68 yuan of 100ml: 0.9g sodium chloride injectionfact, industry slow and steady infusion, the infusion is replaced with weak base, slow turnoverCoupled with the large amount of infusion basis, production companies can effectively protect the enterprise's production scale, lower production costs So after all these years, in fact, the price has not changed much But the industry also said that with the limited anti orders, limit out-patient, the infusion of grass-roots policy continues to fall, the market for large infusion products, the challenge will undoubtedly growing, industry concentration will continue to improve It is learned that China's large infusion of a total of around 300 companies, but annual production of 100 million bottles (bags) there are only 30 In the case of small and medium enterprises within the industry in recent years, hesitant, the head of the enterprise such as Cologne medicine, Double-Crane Pharmaceutical, stone and other four-drug but has a good performance in the market surging The industry believes that the future China will be like a large infusion market or occupy most of the three European markets, showing the three pillars of the situation Overall, industry concentration is rising at this stage, large infusion business if it wants to enhance market competitiveness, gain more market, the need to further strengthen the nutritional and therapeutic drug infusion infusion of research and development and product structure and layout, complete product line, gradually reduce the proportion of basic transfusion, infusion and enhance the proportion of therapeutic drug infusion of high-margin high value-added, the only way to ensure sustainable development of enterprises, will not be easily eliminated .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.